Oct 22, 2018 - With the Mega Millions jackpot at $1.6 billion, lotto fever is sweeping the country.Just remember that even if you beat the odds, lottery winners often regret their large windfalls. Many large jackpot
Oct 22, 2018 - With nine months of the year already behind us, it is time for me to highlight baby DivHut's quarterly dividend income/portfolio progress. Generally speaking, there is not much change in his portfolio
Oct 18, 2018 - FDA Accepts Application for AbbVie's Imbruvica in Specific Blood Cancers, Stocks: ABBV,XSWX:RO, release date:Oct 18, 2018
Oct 18, 2018 - Novartis (NVS) announces encouraging five-year data from late-stage studies on Cosentyx for psoriatic arthritis and ankylosing spondylitis indications.
Oct 17, 2018 - Under Priority Review status, the FDA accepts for review AbbVie's (NYSE:ABBV) marketing application seeking approval for IMBRUVICA (ibrutinib), combined with Roche's (OTCQX:RHHBY) GAZYVA (obinutuzumab
Oct 17, 2018 - EyePoint (EYPT) gains an FDA approval for its eye therapy Yutiq to help cure chronic non-infectious uveitis affecting the posterior segment of the eye.
Oct 16, 2018 - Cheaper copies of the world’s biggest-selling drug will roll out across Europe after a key European patent for Humira expires, but U.S. patients and insurers will have to wait to access less-expensive versions of the blockbuster drug.
Oct 16, 2018 - The stock market's recent sell-off has caused even Grade A dividend aristocrats to go on sale.AbbVie has been hammered for months by numerous concerns over biosimilar rivals to Humira and changes in r
Oct 16, 2018 - One needs much more than $59,000 to make $33,726 in dividend income immediately.If one looks to dividend growth instead of yield, it may take years to decades to accumulate enough dividend income.If a
Oct 16, 2018 - October's top net gain safer Healthcare WallStar is AbbVie. Its projected 23% net gain was 2.3% better than Sanofi's, and 3.4% more than Grifol's result per analyst targets of 10/12/18.WallStars all s